CAPTRUST Financial Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,394
| Closed | -$6K | – | 4501 |
|
|
2022
Q2 | $6K | Hold |
1,394
| – | – | ﹤0.01% | 4034 |
|
|
2022
Q1 | $5K | Sell |
1,394
-99
| -7% | -$355 | ﹤0.01% | 4196 |
|
|
2021
Q4 | $5K | Sell |
1,493
-19
| -1% | -$64 | ﹤0.01% | 4117 |
|
|
2021
Q3 | $5K | Buy |
1,512
+21
| +1% | +$69 | ﹤0.01% | 3978 |
|
|
2021
Q2 | $6K | Sell |
1,491
-21
| -1% | -$85 | ﹤0.01% | 3815 |
|
|
2021
Q1 | $8K | Buy |
1,512
+512
| +51% | +$2.71K | ﹤0.01% | 3567 |
|
|
2020
Q4 | $13K | Hold |
1,000
| – | – | ﹤0.01% | 2468 |
|
|
2020
Q3 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 2294 |
|
|
2020
Q2 | $10K | Buy |
+1,000
| New | +$10K | ﹤0.01% | 2198 |
|
|
2019
Q1 | – | Sell |
-200
| Closed | -$3K | – | 1924 |
|
|
2018
Q4 | $3K | Buy |
+200
| New | +$3K | ﹤0.01% | 1456 |
|